192 related articles for article (PubMed ID: 37253855)
21. Muscle strength, but not body mass index, is associated with mortality in patients with non-alcoholic fatty liver disease.
Charatcharoenwitthaya P; Karaketklang K; Aekplakorn W
J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2393-2404. PubMed ID: 36017777
[TBL] [Abstract][Full Text] [Related]
22. Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.
Mantovani A; Dauriz M; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Oct; 87():1-12. PubMed ID: 29935236
[TBL] [Abstract][Full Text] [Related]
23. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
Hepatol Commun; 2018 Jan; 2(1):48-57. PubMed ID: 29404512
[TBL] [Abstract][Full Text] [Related]
24. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis.
Petrelli F; Manara M; Colombo S; De Santi G; Ghidini M; Mariani M; Iaculli A; Rausa E; Rampulla V; Arru M; Viti M; Lonati V; Ghidini A; Luciani A; Facciorusso A
Neoplasia; 2022 Aug; 30():100809. PubMed ID: 35636146
[TBL] [Abstract][Full Text] [Related]
26. Differential Mortality Outcomes in Real-world Patients with Lean, Nonobese, and Obese Nonalcoholic Fatty Liver Disease.
Nguyen VH; Ha A; Rouillard NA; Le RH; Fong A; Gudapati S; Park JE; Maeda M; Barnett S; Cheung R; Nguyen MH
J Clin Transl Hepatol; 2023 Dec; 11(7):1448-1454. PubMed ID: 38161493
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Zhang Y; Liu X; Zhang H; Wang X
Front Endocrinol (Lausanne); 2022; 13():836455. PubMed ID: 35282455
[TBL] [Abstract][Full Text] [Related]
28. Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities.
Golabi P; Paik JM; Arshad T; Younossi Y; Mishra A; Younossi ZM
Hepatol Commun; 2020 Aug; 4(8):1136-1148. PubMed ID: 32766474
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in mortality and liver-related events in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Zhou H; Chen H; Lu H; Wu B; Zhang S; Gu Y; Zhou G; Xiang J; Yang J
Liver Int; 2024 Jul; 44(7):1600-1609. PubMed ID: 38506430
[TBL] [Abstract][Full Text] [Related]
30. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies.
Li L; Liu DW; Yan HY; Wang ZY; Zhao SH; Wang B
Obes Rev; 2016 Jun; 17(6):510-9. PubMed ID: 27020692
[TBL] [Abstract][Full Text] [Related]
31. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.
Riazi K; Azhari H; Charette JH; Underwood FE; King JA; Afshar EE; Swain MG; Congly SE; Kaplan GG; Shaheen AA
Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):851-861. PubMed ID: 35798021
[TBL] [Abstract][Full Text] [Related]
32. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM; Koenig AB; Abdelatif D; Fazel Y; Henry L; Wymer M
Hepatology; 2016 Jul; 64(1):73-84. PubMed ID: 26707365
[TBL] [Abstract][Full Text] [Related]
33. Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis.
Liu J; Tian Y; Fu X; Mu C; Yao M; Ni Y; Liu Y; Li Z
Chin Med J (Engl); 2022 Jul; 135(14):1682-1691. PubMed ID: 36070463
[TBL] [Abstract][Full Text] [Related]
34. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
[TBL] [Abstract][Full Text] [Related]
35. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.
Mantovani A; Zaza G; Byrne CD; Lonardo A; Zoppini G; Bonora E; Targher G
Metabolism; 2018 Feb; 79():64-76. PubMed ID: 29137912
[TBL] [Abstract][Full Text] [Related]
36. Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Thomas JA; Kendall BJ; Dalais C; Macdonald GA; Thrift AP
Eur J Cancer; 2022 Sep; 173():250-262. PubMed ID: 35944373
[TBL] [Abstract][Full Text] [Related]
37. The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis.
Wu Y; Zheng Q; Zou B; Yeo YH; Li X; Li J; Xie X; Feng Y; Stave CD; Zhu Q; Cheung R; Nguyen MH
Hepatol Int; 2020 Mar; 14(2):259-269. PubMed ID: 32130675
[TBL] [Abstract][Full Text] [Related]
38. Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects.
Feldman A; Wernly B; Strebinger G; Eder SK; Zandanell S; Niederseer D; Strasser M; Haufe H; Sotlar K; Paulweber B; Datz C; Aigner E
J Gastrointestin Liver Dis; 2021 Sep; 30(3):366-373. PubMed ID: 34375373
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.
Lombardi R; Onali S; Thorburn D; Davidson BR; Gurusamy KS; Tsochatzis E
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011640. PubMed ID: 28358980
[TBL] [Abstract][Full Text] [Related]
40. The safety and efficacy evaluation of sodium-glucose co-transporter 2 inhibitors for patients with non-alcoholic fatty liver disease: An updated meta-analysis.
Mo M; Huang Z; Liang Y; Liao Y; Xia N
Dig Liver Dis; 2022 Apr; 54(4):461-468. PubMed ID: 34507895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
